477 Capecitabine dose modification minimises side effects without compromising efficacy in pretreated metastatic breast cancer (MBC)

✍ Scribed by R. Leonard; B.T. Hennessy; J.L. Blum; J. O'Shaughnessy

• Book ID: 119601483
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 49 KB
• Volume: 8
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(10)70498-5